title: Theranos phenomenon - part 2.
abstract: Theranos' Chief Executive Officer recently published a paper in The Wall Street Journal committing to submit all of their tests for FDA approval and renewing her promise that self-testing by the general public will empower people to detect asymptomatic disease early, which will lead to life-saving therapeutic or preventive measures. This opinion paper provides additional information on the benefits and harms of self-testing and self-interpretation of laboratory tests by asymptomatic individuals. We conclude that the health benefit claims of Theranos are hypothetical and they are not supported by evidence. Until such evidence is provided, self-testing of the healthy population should be discouraged.
authors.forename: Michelle
authors.initials: M
authors.lastname: Li
authors.forename: Eleftherios P
authors.initials: EP
authors.lastname: Diamandis
mesh_terms: D058070:Asymptomatic Diseases; D019937:Diagnostic Techniques and Procedures; D042241:Early Diagnosis; D006801:Humans; D007342:Insurance Benefits; D012648:Self Care; D014481:United States; D014486:United States Food and Drug Administration